HSP70 1A Antikörper

Produktnummer ABIN781228

Dieses Anti-HSP70 1A-Antikörper ist ein Maus Monoklonal-Antikörper zur Detektion von HSP70 1A in WB und ELISA. Geeignet für Human.

Kurzübersicht für HSP70 1A Antikörper (ABIN781228)

Target: HSP70 1A (HSPA1A) (Heat Shock 70kDa Protein 1A (HSPA1A))

Reaktivität: Human

Wirt: Maus

Klonalität: Monoklonal

Konjugat: Dieser HSP70 1A Antikörper ist unkonjugiert

Applikation: Western Blotting (WB), ELISA

Produktdetails anti-HSP70 1A Antikörper

Spezifität: Cytoplasm

Aufreinigung: Protein G-Sepharose affinity purified.

Immunogen: Recombinant fragment of human HSPA1A (C-terminus).

Isotyp: IgG

Anwendungsinformationen

Applikationshinweise: Recommended dilutions. ELISA: 1/5000 - 1/20000. WB: 1/100-1/2000.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Konzentration: 50µg/50µl

Buffer: 0.02% Sodium Azide and 50% glycerol, 1%BSA, PBS, pH7.4.

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Lagerung: -20 °C

Details zu HSP70 1A

Target: HSP70 1A (HSPA1A) (Heat Shock 70kDa Protein 1A (HSPA1A))

Andere Bezeichnung: HSPA1A

Hintergrund: Hsp70 genes encode abundant heat-inducible 70-kDa hsps (hsp70s). In most eukaryotes hsp70 genes exist as part of a multigene family. They are found in most cellular compartments of eukaryotes including nuclei, mitochondria, chloroplasts, the endoplasmic reticulum and the cytosol, as well as in bacteria. The genes show a high degree of conservation, having at least 5O% identity. The structure of this ATP binding domain displays multiple features of nucleotide binding proteins. The molecular chaperones of the hsp70 family recognize and bind to nascent polypeptide chains as well as partially folded intermediates of proteins preventing their aggregation and misfolding.

Molekulargewicht: 70kDa

NCBI Accession: NM_005345

Pathways: Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process